55117-80-1 Usage
Uses
Used in Pharmaceutical Industry:
1-(4-Chlorophenyl)-2-methylpiperazine is used as a starting material for the synthesis of various medications, including antihistamines and antipsychotic drugs, due to its unique chemical structure and potential therapeutic effects.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(4-Chlorophenyl)-2-methylpiperazine is utilized as a scaffold for the design and synthesis of new chemical entities for drug development. Its versatile structure allows for the creation of novel compounds with potential applications in treating various medical conditions.
As a Building Block for Drug Discovery:
1-(4-Chlorophenyl)-2-methylpiperazine is employed as a potentially useful building block in drug discovery, enabling researchers to explore its biological activity and therapeutic potential in the development of new medications.
Check Digit Verification of cas no
The CAS Registry Mumber 55117-80-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,1,1 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 55117-80:
(7*5)+(6*5)+(5*1)+(4*1)+(3*7)+(2*8)+(1*0)=111
111 % 10 = 1
So 55117-80-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H15ClN2/c1-9-8-13-6-7-14(9)11-4-2-10(12)3-5-11/h2-5,9,13H,6-8H2,1H3
55117-80-1Relevant academic research and scientific papers
CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
-
Paragraph 1528, (2016/02/21)
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
Chemokine receptor antagonists and methods of use thereof
-
, (2008/06/13)
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.
